# US 2020/0392071 A1 · Gene cluster for the biosynthetic production of tetracycline compounds in a heterologous host

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0392071 A1
- Document ID: US20200392071A1
- Status: Published application
- Kind: A1
- Application number: 16/954,461
- Filed: 2018-12-21
- Published: 2020-12-17
- Earliest claimed: 2017-12-22
- Applicants: Helmholtz-Zentrum FüR Infektionsforschung GmbH; Acies Bio D.O.O.
- Inventors: Rolf MÜLLER; Tadeja LUKEZIC; Maja REMSKAR; Nestor ZABURANNYI; Chantal BADER; Asfandyar SIKANDAR; Jesko KÖHNKE
- Web page: https://patentgrep.com/patent/US20200392071A1

## CPC

- C07C 237/26: of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
- C07C 225/20: having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
- C07K 14/36: from Actinomyces; from Streptomyces (G)
- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 9/0069: {acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)}
- C12N 9/0071: {acting on paired donors with incorporation of molecular oxygen (1.14)}
- C12N 9/1007: {Methyltransferases (general) (2.1.1.)}
- C12N 9/1029: {transferring groups other than amino-acyl groups (2.3.1)}
- C12N 9/104: {Aminoacyltransferases (2.3.2)}
- C12N 9/1048: {Glycosyltransferases (2.4)}
- C12N 9/93: {Ligases (6)}
- C12N 15/63: Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N 2800/101: for bacteria
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to the application of biosynthetic engineering for the heterologous expression of a gene cluster for the biosynthesis of tetracycline compounds, notably chelocardin and its analogues. More particularly, the present invention pertains to a gene cluster encoding polypeptides involved in tetracycline biosynthesis, which gene cluster is suitable for heterologous expression of the biosynthetic pathway in a host cell. The present invention further pertains to DNA construct s comprising the gene cluster, to recombinant heterologous host cell s comprising the gene cluster or the DNA construct, to processes for the biosynthetic production of a tetracycline compound employing such recombinant host cells, and to tetracycline compounds thereby produced. The present invention also pertains to fusion proteins which are useful in the production of tetracycline compounds.

## Claims

### Claim 1

A gene cluster encoding polypeptides involved in the biosynthesis of a tetracycline, wherein said gene cluster includes all of the nucleotide sequences (1) to (19):
(1) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 1 and which has the same functional property as the polypeptide of SEQ ID NO: 1 [ChdP];
(2) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 2 and which has the same functional property as the polypeptide of SEQ ID NO: 2 [ChdK];
(3) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 3 and which has the same functional property as the polypeptide of SEQ ID NO: 3 [ChdS];
(4) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 4 and which has the same functional property as the polypeptide of SEQ ID NO: 4 [ChdQI];
(5) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 5 and which has the same functional property as the polypeptide of SEQ ID NO: 5 [ChdQII];
(6) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 6 and which has the same functional property as the polypeptide of SEQ ID NO: 6 [ChdX];
(7) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 7 and which has the same functional property as the polypeptide of SEQ ID NO: 7 [ChdL];
(8) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 8 and which has the same functional property as the polypeptide of SEQ ID NO: 8 [ChdT];
(9) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 9 and which has the same functional property as the polypeptide of SEQ ID NO: 9 [ChdMI];
(10) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 10 and which has the same functional property as the polypeptide of SEQ ID NO: 10 [ChdMII];
(11) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 11 and which has the same functional property as the polypeptide of SEQ ID NO: 11 [ChdN];
(12) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 12 and which has the same functional property as the polypeptide of SEQ ID NO: 12 [ChdGIV];
(13) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 13 and which has the same functional property as the polypeptide of SEQ ID NO: 13 [ChdTn];
(14) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 14 and which has the same functional property as the polypeptide of SEQ ID NO: 14 [ChdR];
(15) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 15 and which has the same functional property as the polypeptide of SEQ ID NO: 15 [ChdA];
(16) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 16 and which has the same functional property as the polypeptide of SEQ ID NO: 16 [ChdOI];
(17) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 17 and which has the same functional property n as the polypeptide of SEQ ID NO: 17 [ChdOIII];
(18) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 18 and which has the same functional property as the polypeptide of SEQ ID NO: 18 [ChdOII]; and
(19) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 19 and which has the same functional property as the polypeptide of SEQ ID NO: 19 [ChdY].

### Claim 2 (depends on 1)

The gene cluster according to claim 1, wherein said gene cluster further comprises at least one of the nucleotide sequences (20) and (21):
(20) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 20 and which has the same functional property as the polypeptide of SEQ ID NO: 20 [SARP/ChdB]; and
(21) a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 21 and which has the same functional property as the polypeptide of SEQ ID NO: 21 [LuxR/ChdC].

### Claim 3 (depends on 2)

The gene cluster according to claim 2, wherein said gene cluster comprises both nucleotide sequences (20) and (21).

### Claim 4 (depends on 1, 2, 3)

The gene cluster according to any one of claims 1 to 3, wherein the nucleotide sequences (18) and (19) are linked to form a fusion protein of the respective polypeptides encoded by them.

### Claim 5 (depends on 4)

The gene cluster according to claim 4, wherein the fusion protein comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 22 and has the same functional properties as the polypeptides of SEQ ID NO: 18 and SEQ ID NO: 19 [ChdOII+ChdY].

### Claim 6 (depends on 1, 2, 3, 4, 5)

The gene cluster according to any one of claims 1 to 5, wherein the nucleotide sequences (7) and (17) are linked to form a fusion protein of the respective polypeptides encoded by them.

### Claim 7 (depends on 6)

The gene cluster according to claim 6, wherein the fusion protein comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 23 and has the same functional properties as the polypeptides of SEQ ID NO: 7 and SEQ ID NO: 17 [ChdL+ChdOIII].

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

A DNA construct comprising the gene cluster according to any one of claims 1 to 7.

### Claim 9 (depends on 8)

The DNA construct according to claim 8, wherein said DNA construct further comprises a nucleotide sequence encoding a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 24 and which has the same functional property as the polypeptide of SEQ ID NO: 24 [OxyD].

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

A recombinant host cell comprising the gene cluster according to any one of claims 1 to 7 or the DNA construct according to claim 8 or 9, wherein the gene cluster or DNA construct is heterologous to said host cell.

### Claim 11 (depends on 10)

The recombinant host cell according to claim 10, which heterologously expresses the polypeptides encoded by the gene cluster.

### Claim 12 (depends on 10, 11)

The recombinant host cell according to claim 10 or 11, which heterologously expresses a polypeptide which comprises an amino acid sequence having at least 80%, such as at least 85%, sequence identity with the polypeptide of SEQ ID NO: 24 and which has the same functional property as the polypeptide of SEQ ID NO: 24 [OxyD].

### Claim 13 (depends on 10, 11, 12)

The recombinant host cell according to any one of claims 10 to 12, which is a bacterium.

### Claim 14 (depends on 10, 11, 12, 13)

A process for the biosynthetic production of a tetracycline, said process comprises the steps of a) cultivating a recombinant host cell according to any one of claims 10 to 13 in the presence of a suitable substrate under conditions conducive to the production of said tetracycline and, optionally, b) recovering the tetracycline from the medium employed in cultivation.

### Claim 15 (depends on 14)

The process according to claim 14, wherein the tetracycline is chelocardin or an analogue thereof.
